26 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• SINTX Technologies, Inc. SINT stock rose 37.9% to $2.44 during Thursday's pre-market session. The market cap stands at $1.3 million.
• SELLAS Life Sciences, Inc. SLS shares rose 24.5% to $0.18. The market cap seems to be at $41.5 million.
• Fibrocell Science, Inc. FCSC stock increased by 11.4% to $1.95. The market cap stands at $17.5 million.
• Guardion Health Sciences, Inc. GHSI shares surged 10.6% to $0.30. The market value of their outstanding shares is at $28.3 million.
• Restoration Robotics, Inc. HAIR stock moved upwards by 8.7% to $0.75. The market cap stands at $27.7 million.
• InMode, Inc. INMD shares rose 7.7% to $17.50.
• Geron, Inc. GERN stock moved upwards by 7.0% to $1.38. The market cap seems to be at $391.6 million.
• Acorda Therapeutics, Inc. ACOR shares rose 4.6% to $2.50. The market cap seems to be at $445.7 million. The most recent rating by H.C. Wainwright, on August 14, is at Neutral, with a price target of $6.00.
• Phio Pharmaceuticals, Inc. PHIO shares moved upwards by 4.1% to $0.36. The market cap stands at $9.0 million.
• Oncolytics Biotech, Inc. ONCY stock surged 3.5% to $0.60. The market cap stands at $51.3 million.
• Xenetic Biosciences, Inc. XBIO shares surged 3.5% to $1.80. The market cap stands at $7.0 million.
• Mallinckrodt, Inc. MNK stock moved upwards by 3.1% to $4.78. The most recent rating by Barclays, on June 11, is at Equal-Weight, with a price target of $11.00.
• Valeritas Holdings, Inc. VLRX shares surged 2.6% to $2.36. The market cap seems to be at $69.7 million.

Losers

• Akari Therapeutics, Inc. AKTX shares declined 16.8% to $2.43 during Thursday's pre-market session. The market cap stands at $28.6 million.
• Canopy Growth, Inc. CGC shares fell 11.8% to $28.15. The market value of their outstanding shares is at $4.2 billion. The most recent rating by Ladenburg Thalmann, on July 17, is at Buy, with a price target of $50.00.
• Jaguar Health, Inc. JAGX stock plummeted 11.8% to $1.35. The market cap seems to be at $9.1 million.
• Genfit, Inc. GNFT stock plummeted 4.6% to $14.92. The market cap seems to be at $638.7 million.
• Novavax, Inc. NVAX stock declined 4.0% to $5.80.
• Genmab, Inc. GMAB shares fell 3.4% to $19.91. According to the most recent rating by Morgan Stanley, on August 12, the current rating is at Overweight.
• Cellectis, Inc. CLLS stock fell 3.0% to $11.84. The market cap seems to be at $653.4 million. According to the most recent rating by BTIG, on August 09, the current rating is at Buy.
• Aphria, Inc. APHA shares plummeted 3.0% to $6.21. The market cap stands at $1.3 billion. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.
• Aurora Cannabis, Inc. ACB shares fell 2.6% to $5.93. The market cap seems to be at $6.4 billion.
• Tilray, Inc. TLRY shares decreased by 2.5% to $38.05. The market cap stands at $6.3 billion. According to the most recent rating by Ladenburg Thalmann, on July 17, the current rating is at Neutral.
• Deciphera Pharmaceuticals, Inc. DCPH shares decreased by 2.3% to $36.99. The market value of their outstanding shares is at $844.5 million. The most recent rating by Canaccord Genuity, on August 14, is at Buy, with a price target of $65.00.
• HEXO, Inc. HEXO shares decreased by 2.2% to $4.49. The market cap seems to be at $1.0 billion. According to the most recent rating by Oppenheimer, on June 25, the current rating is at Perform.
• Cronos Group, Inc. CRON stock fell 2.0% to $13.00. The most recent rating by Piper Jaffray, on August 13, is at Overweight, with a price target of $18.00.